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ABSTRACT 
In this dissertation a study of enhanced hyperthermia for cancer treatment through the use of 
magnetic nanoparticles is presented. Hyperthermia has been in use for many years, as a potential 
alternative method in cancer treatment, and high frequency microwave radiation has been used 
successfully to raise the tumor temperature to around 42C in superficial tumors without causing 
damage to surrounding healthy tissues. Magnetic fluid hyperthermia involves the use of 
magnetic nanoparticles injected into the tumor before exposure to microwave radiation. The 
magnetic energy in the nanoparticles is converted into heat allowing for a more rapid rise of 
temperature in the tumor to the desired level. In addition, the nanoparticles allow the 
electromagnetic absorption to be focused in the tumor and can be used to treat deep tumors in 
organs, such as the liver.  Iron oxide magnetic nanoparticles were considered for this study as 
they are non-toxic and bio-compatible. For the case of breast cancer, the values for the 
temperature and specific absorption rate (SAR) in the tumor and in the healthy tissue were 
obtained through simulations and validated by measurement done on phantom models. Various 
characteristics of the nanoparticles such as radius, magnetic susceptibility and concentration 
were considered. In order to take the effect of the blood flow, which causes cooling and helps 
maintain the body temperature, various blood perfusion rates for a tumor in the liver were 
studied. A human male model in SEMCAD X, in which blood flow can be adjusted, was used for 
simulations. The tumor was injected with the nanoparticles and the change in temperature upon 
exposure to electromagnetic radiation was observed. The simulated results were compared with 
measured results on a liver phantom model in which saline solution was used to model blood 
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CHAPTER 1: INTRODUCTION 
 
 
1.1.Overview of Medical Applications of High Frequency Radiation 
The radio frequency spectrum spans the range of 3 kHz to several hundred GHz. The 
microwave region, which is from 1 GHz to around 30 GHz, is the portion of the electromagnetic 
spectrum that is nonionizing, that is, this radiation does not have enough energy to 
ionize atoms or molecules. Thus, this nonionizing radiation can be very useful in biomedical 
applications [1, 2]. Transmission, absorption and reflection of the electromagnetic energy will 
depend on the body size, tissue properties, and the frequency of the radiation [3]. 
Non-ionizing electromagnetic fields, in the RF/MW range, have been used in various 
medical treatments. The most common applications are diagnostic imaging and therapeutic 
applications.  
1.1.1. Microwave Imaging 
Currently available diagnostic screening systems for cancer include X-ray computed 
tomography (CT) and mammography. They are effective at detecting early signs of tumors, 
however, they are far from perfect, subjecting patients to ionizing radiation. Mammography can 
inflict discomfort on women who are undergoing screening because of the compression of the 
breast that is required to produce diagnostically useful images. 
A better, cheaper, and safer way to detect breast cancer is possible with microwaves. 
Microwave imaging relies upon the known differences in the dielectric properties of cancerous 
tissue and normal tissue, that is, their ability to conduct electricity or sustain an electric field. In 
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the technique, the tissue is irradiated using an array of antennas surrounding the tissue. An 
example of the set up for use with a breast tissue is shown in Figure 1. Each antenna illuminates 
the tissue individually with a very low power microwave signal, with approximately one one-
thousandth the power of a cell phone, while the other antennas receive the signals transmitted 
through the tissue. This process is repeated for each antenna, providing data that can be used to 








Figure 1. Microwave imaging of breast tissue 
 
 
1.1.2. Thermal Therapy 
In thermal therapy, the body tissue is exposed to high temperatures to damage and kill 
cancer cells or to make cancer cells more sensitive to the effects of radiation and certain 
anticancer drugs.  
Absorption of RF/MW radiation which results in the heating of the body tissues depends 




Frequencies greater than 10,000 MHz (10 GHz) are absorbed mostly in the outer skin. 
Frequencies between 10,000 MHz and 2500 MHz penetrate more deeply, approximately 3 mm to 
2 cm into the tissue. Frequencies of 2500 MHz to 1300 MHz penetrate deep enough to cause 
damage to internal organs by overheating of the tissue [4]. 
There are a growing number of clinical applications of thermal therapy that benefit 
patients with a variety of diseases, such as hyperthermia and thermal ablation.  
Hyperthermia: In the late 1950s, it was determined that raising the tumor to temperatures 
of 42 - 45 C made them more sensitive to radiation/chemotherapy. This technique has been 
proven effective over the past 20 years through clinical trials. The combination of hyperthermia 
with radiation therapy has been shown to and improve treatment efficacy, tumor response and 
duration of local tumor control. Hyperthermia has been proven successful in the treatment of 
recurrent chest wall breast cancer, melanoma, locally advanced head and neck cancer, and 
several other cancers. Today, in some countries such as The Netherlands and Germany, 
hyperthermia is part of standard cancer care.  
Thermal ablation: In this treatment the tissue is destroyed by localized heating or 
freezing. Various energy sources including laser, ultrasound and microwaves are found to be 
minimally invasive, and potentially useful for this therapy. 
Today, according the Society for Thermal Medicine, about 100,000 patients with cancers 
of the liver, lung, kidney and bone are annually treated worldwide using thermal therapy, as it 
provides local tumor control with minimal side effects. About a dozen FDA approved devices 
are available, with novel devices in the pipeline [5]. In addition, the combination of thermal 
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ablation with chemo- or radiation therapy, and immunotherapy, is being pursued in clinical trials 
[6, 7]. 
1.2. Motivation for the Research 
Cancer remains one of the leading causes of death in the world. New methods for 
treatment of cancer that have been implemented have been successful, but the results are still 
limited. The use of hyperthermia along with conventional cancer treatment such as 
chemotherapy and radiation has been successful in many cancer treatments [6, 7]. In this 
approach, the cancerous tumors are heated to a temperature between 40 and 45°C for a specific 
period of time which renders tumor cells more sensitive to radiation and chemotherapy. The 
increase in temperature stimulates blood flow in the tumor, increases oxygenation and hence 
makes the treatment more effective. High temperatures can kill cancer cells, but they also can 
injure or kill normal cells and tissues. Temperatures above 42°C can cause burns and blisters in 
healthy tissue. Consequentially, during hyperthermia treatment, the temperature in the tumor and 
healthy tissue has to be closely monitored. 
In hyperthermia, suitable applicators (antennas) are used to provide energy to penetrate 
the body tissues. A majority of the applicators provide good energy deposition in superficial 
tumors [8, 9]. For treating deep seated tumors, the frequency of the applicators is lower, and 
typically and array of applicators is used as a single applicator may not provide the necessary 
energy. With the hyperthermia systems developed for regional hyperthermia of deep seated 
tumors, selective heating of those regions is still very difficult. Moreover, in almost all clinical 
trials patients experienced local pain and discomfort and the temperature in healthy tissues was 
also high [10]. 
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The main concern in deep hyperthermia is the power deposition in tumors and the 
temperature monitoring during treatment. The current procedures have a limitation on the body 
target sites that are too difficult to treat. There is a large need for alternative effective options in 
hyperthermia for providing deep seated power deposition various regions of the body, without 
affecting healthy surrounding tissues and organs. 
Hence, in this research we investigate an enhanced hyperthermia treatment through the 
use of magnetic nanoparticles. 
 
1.3. Dissertation Outline  
This dissertation consists of 7 major sections. The first chapter is an overview of the use 
of high frequency in medicine. It introduces the hyperthermia cancer treatment and the 
motivation for this research.  
Chapter 2 covers the biological and physical aspects of hyperthermia. The biological 
aspects of hyperthermia refers to the electromagnetic propagation in biological tissues and the 
physical aspects cover the applicators used in hyperthermia treatments.  
Chapter 3 explains in detail the heat transfer in microwave hyperthermia using the 
bioheat equation and study the specific absorption rate.  
Chapter 4 details the use of magnetic nanoparticles in hyperthermia. The nanoparticle 
targeting mechanisms and the heat generated by using nanoparticles during hyperthermia 
treatment are presented. 
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Chapter 5 focuses on a primary study of microwave hyperthermia in breast cancer 
treatment using magnetic nanoparticles. The results of simulation and measurement are included 
in this chapter.  
Chapter 6 presents results for an enhanced hyperthermia treatment for liver cancer with 
realistic human models incorporating the blood perfusion rate. Here, the results of simulations 
and measurement are presented.  
Conclusions of this research are presented in Chapter 7. 
  
7 
CHAPTER 2: BIOLOGICAL AND PHYSICAL ASPECTS OF 
HYPERTHERMIA   
 
 
2.1. RF/Microwave Propagation in Biological Tissues 
The interaction of the high frequency fields with the biological tissues is determined to a 
large extent by the characteristics of the tissue permittivity , permeability  and conductivity . 
Biological tissues are non-magnetic and hence the permeability  does not play a major role. 
There are several sources in the literature [11, 12] where the ,  and  values for various tissues 
such as muscles, bone, blood, liver, kidney, etc., at various frequencies are provided. Table 1 
shows the dielectric properties of human tissues at 3 different frequencies 915 MHz, 2.45 GHz 
and 10 GHz. Heat absorption will be greatest in tissues that have high water content, such as 
muscle, with less heat absorption taking place in bone and fat [12]. 
 
2.2. Electromagnetic Waves Propagating in Biological Tissues 
When the biological tissues are exposed to RF/Microwave radiation, the characteristics of 
the tissues will determine the amount of energy reflected by or absorbed in the tissue. 
Consider a tissue with an incident linearly polarized EM wave propagating along z 
direction, as shown in Figure 2, with its E field polarized along x direction and H field polarized 
along y direction.  𝐸𝑖 is the incident electric field, 𝐸𝑡 is the transmitted electric field and 𝐸𝑟 is the 










Figure 2. Electric field propagation in biological tissues 
 





were 𝐸0 is the amplitude of the incident wave and  is the attenuation constant of the medium. 
The skin depth 𝛿, is the distance at which the field reduces to 37% of its value at the 
interface, is equals to 1 𝛼⁄ .  
The frequency of the radiation and the dielectric properties of the tissue determine the 
penetration of energy in the human tissues. Figure 3 shows the effect of the skin depth on the 
power absorbed in fat and muscle tissue at 2.45 GHz. The  skin depth for fat is 0.117 m and for 
muscle 0.022 m, calculated using values in Table 1. At this frequency, the penetration is deeper 









The skin effect implies that, when using microwaves for a medical application, the higher the 
frequency, the smaller the penetration, which may lower the efficiency of the application. Hence, 
the choice of frequency is important. It also implies that if a human being, for instance, is 












































Table 1. Dielectric properties of human tissues at different frequencies 
 
 
915 MHz 2.45 GHz 
Tissue 
Name 
Conductivity Relative Loss Conductivity Relative Loss 
[S/m] permittivity tangent [S/m] permittivity tangent 
Bladder 0.38506 18.923 0.39976 0.68532 18.001 0.27933 
Blood 1.5445 61.314 0.49487 2.5448 58.264 0.32046 
Blood 
Vessel 
0.70087 44.741 0.30774 1.4353 42.531 0.2476 
Bone 
Cancello 
0.34353 20.756 0.32515 0.80517 18.548 0.31849 
Bone 
Cortical 
0.14512 12.44 0.22919 0.39431 11.381 0.2542 
Bone 
Marrow 
0.040588 5.5014 0.14494 0.095037 5.2969 0.13164 
Breast Fat 0.049523 5.4219 0.17944 0.13704 5.1467 0.19535 
Cartilage 0.7892 42.6 0.36394 1.7559 38.77 0.33228 
Colon 1.087 57.867 0.36901 2.0383 53.879 0.27757 
Cornea 1.4008 55.172 0.49878 2.2954 51.615 0.32629 
Fat 0.051402 5.4596 0.18496 0.10452 5.2801 0.14524 
GallBladder 1.2614 59.118 0.41918 2.059 57.634 0.26212 
Heart 1.2378 59.796 0.40668 2.2561 54.814 0.30199 
Kidney 1.4007 58.556 0.46991 2.4295 52.742 0.33797 
Liver 0.86121 46.764 0.36179 1.6864 43.035 0.28751 
Muscle 0.94809 54.997 0.33866 1.7388 52.729 0.24194 
Nerve 0.57759 32.486 0.34929 1.0886 30.145 0.26494 
Prostate 1.2159 60.506 0.39477 2.1676 57.551 0.27633 
Retina 1.1725 55.23 0.41706 2.0332 52.628 0.28345 
Skin 0.87169 41.329 0.41435 1.464 38.007 0.28262 
Small 
Intestin 
2.173 59.389 0.71881 3.1731 54.425 0.42777 
Spinal Cord 0.57759 32.486 0.34929 1.0886 30.145 0.26494 
Stomach 1.1932 65.02 0.36053 2.2105 62.158 0.36053 





The amount of power deposition in the body is be expressed through the specific 
absorption rate (SAR), measured in watts per kilogram of mass tissue and is a simple and useful 
value for quantifying the interactions of RF/microwave radiation with living systems. The SAR 
is defined as the ratio of the total power absorbed in the exposed body to the mass in which it is 







where E is the root mean square electric field [V/m],  is the conductivity [S/m], and  is the 




The normal temperature in a human body is 37°C. Hyperthermia refers to increase in the 
normal temperature in the human body. In hyperthermia treatment, cancerous cells temperatures 
are elevated to the range between 42 - 45°C, so as to destroy them. This treatment can be done 
without substantial damage to healthy tissues and with minimal side effects. Hyperthermia 
cancer treatment is been used nowadays in combination with radiotherapy and chemotherapy.  
Hyperthermia can be used to treat specific tumor locations or for the entire body. In local 
hyperthermia, used to increase the temperature in a specific area that contains a tumor, the heat 
generation can be achieved by external applicators to treat tumors near the skin’s surface or with 
probes to reach deep-seated cancerous tissues. Regional hyperthermia is used for larger or 
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multiple tumor locations or to treat cancers that have spread to several regions. Here, a larger 
part of the body is heated to destroy the cancerous cells [13, 14]. This treatment is also usually 
combined with chemotherapy or radiation therapy. 
In hyperthermia treatment, the high frequency electromagnetic energy is applied to the 
tissue using either external or internal applicators depending on the tumor location. Internal 
applicators use a needle or probe to release the energy directly into the tumor, and external 
applicators radiate the tissue from outside.  
Healthy tissues can also absorb electromagnetic energy and get heated leading to burns, 
blisters, and discomfort. Thus, it is critical to monitor temperatures in healthy tissues during 
hyperthermia treatment.  
 
2.4. Hyperthermia Applicators 
Electromagnetic hyperthermia used before the 1950s was not well developed and mainly 
empirical [15, 16]. After 1950, hyperthermia as a separate treatment modality started [17]. 
Research work was focused on the development of quasi-static or radiative techniques using 
electromagnetic energy. Initially, these devices operated only at the ISM (Industry Science and 
Medicine) frequencies, and typically had a single power source, one applicator and limited 
treatment area. Electric and magnetic field were used to deliver the electromagnetic energy to the 
patient through the air. Over the years, various applicators were developed to provide better 
tissue deposition and maintain heterogeneous skin cooling. In addition, several advanced 
computer aided design allowed the design of efficient applicators [18-22].  
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2.4.1. Inductive Heating 
For inductive heating, an inductive concentric coil is placed around the patient avoiding 
contact between the patient and the applicator. The electromagnetic energy is transferred through 
magnetic fields. It was found that one main disadvantage of these devices is that the power 
deposition at the center of the target tissue is very low [23].  
In order to solve this problem, a helical coil applicator with a coaxial pair magnetic 
system was developed [24]. This device creates homogeneous energy deposition in the patient by 
moving the applicator around its longitudinal axis. It operates at its resonance frequency and 
creates eddy currents by the inductive field component. However, this device had limited spatial 
control of the energy deposition and the blood perfusion played an important role in the tumor 
heating.  
2.4.2. Capacitive Heating 
Here, the electric field is used to transfer the electromagnetic energy to the tissue, with  
one electrode placed below and one above the patient [25]. The energy deposition depends on the 
sizes of electrodes and the electric field. It is seen that there is a high power deposition in the 
subcutaneous fatty tissue. The disadvantages of this devices is that the energy distribution will 
depend only on the electrodes position and size and hence the treatment needs to be stopped to 






2.4.3. Radiation Heating  
Cylindrical waveguides and dipole antennas are used as radiating devices for radiation 
heating [26]. The main disadvantage with these applicators is that the volume treated is very 
small and the antennas used have low directivity. The radiating elements are divided into devices 
for use in superficial hyperthermia and for deep hyperthermia, based on the frequency and tumor 
location.  
When the tumors are superficial, less number of applicators are needed. Multi-elements 
applicators are used to obtain a high heterogeneity of SAR distribution [27-30].  
2.4.4. Interstitial Applicators 
The electromagnetic energy can also be delivered to the diseased tissue through an 
invasive process where antennas (needles) are inserted into the tumor. These are placed inside 
the patient using imaging guidance, such as CT (computed tomography) or ultrasound. These 
applicators can also be used during an open surgical procedure to target and ablate the diseased 
soft-tissue [31]. 
Due to the invasive nature of this technique, these applicators can cause discomfort and 
complications prior to, during and after each treatment.   
15 




For hyperthermia, the temperature increase in the tissues during electromagnetic heating 
needs to be determined accurately.  Heat transfer analysis often needs to simultaneously deal 
with transient and spatial heating inside biological bodies. The Penne’s bioheat transfer equation, 
which describes the exchange magnitude of heat transfer between tissue and blood, is widely 
used to solve the temperature distribution for thermal therapy [32-33]. The Penne’s bioheat 
transfer equation is based on the assumption that all heat transfer between the tissue and the 
blood occurs in the capillaries, and neglects the local effects where “thermally significant” 
blood vessels do not appear in the temperature field. For localized hyperthermia, Ocheltree and 
Frizzell [34 -35] demonstrated the analytical formulations for both transient and steady state of 
three tumor models via the Penne’s bioheat transfer equation. 
3.2. Penne’s Bioheat Equation 







− ωb𝜌𝑏cb(T − Ta) + Qmet + Qext (3) 
 
where 𝜌𝑡 is the tissue density, 𝑐𝑡 is the specific heat of tissue, 𝑇 is the tissue temperature, ωb is 
the blood perfusion rate, 𝜌𝑏 is the blood density, 𝑐𝑏 is the specific heat of blood, 𝑇𝑎 is the tissue 
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temperature, 𝑘 is the thermal conductivity of tissue, 𝑄𝑚𝑒𝑡 is the heat coming from metabolism, 








where 𝜎𝑡 is the electrical conductivity of the tissue and E is the electric field generated by the 
EM applicator. By analyzing (4), it is evident that only the E field is taken into account to obtain 
the temperature increase in tissues and tumors. Although the EM applicator generates E and H 
fields, the effect of the H field is neglected because biological tissues are nonmagnetic.  
 
3.3. Specific Absorption Rate (SAR) 
The specific absorption rate (SAR) is a measure of the energy absorbed by the tissue due 
to electromagnetic radiation and is related to the increase in temperature in the tissue. The SAR 
is the ratio of the total power absorbed in the exposed body to the mass in which it is absorbed, 
as explained in Section 2.2. The amount of energy absorbed by the tissue depends on several 
factors including frequency, dielectric property of the tissue, irradiating time exposure, intensity 
of electromagnetic radiation, and water content of the tissue.  
As exposure to high frequency electromagnetic radiation can cause damage to tissues, 
there are strict safety guidelines for exposure that are set by the Federal Communications 
Commission FCC [36, 37]. 
In sensitive organs, small temperature increases can produce severe physiological effects. 
An increase of approximately 1–5°C in human body temperature can cause numerous 
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malformations, temporary infertility in males, brain lesions, and blood chemistry changes. Even 
a small temperature increase in human body (approximately 1°C) can lead to altered production 
of hormones and suppressed immune response [36]. 
At high frequencies human tissues with finite electric conductivity are generally lossy 
mediums and are usually neither good dielectric materials nor good conductors and as 
electromagnetic waves propagate through the human tissues, the energy of EM waves is 
absorbed by the tissues.  
The basic restrictions for whole body average SAR, and localized SAR for frequencies 
between 1 Hz and 10 GHz, according to IEEE Standards, are presented in Table 2 [36]: 
Table 2. Basic restrictions for time varying electric and magnetic fields for frequencies up to 10 GHz. 
 
Frequency Range Localized SAR 





Up to 100 kHz - - 
100 kHz – 10 MHz 2 4 
10 MHz – 10 GHz 2 4 
 
In the low-frequency range, there are currently few data relating transient currents to 
health effects. The ICNIRP therefore recommends that the restrictions on current densities 
induced by transient or very short-term peak fields be regarded as instantaneous values which 
should not be time-averaged [36]. 
The SAR values in the tissue which are an indicator of energy absorption, can be related 
to the temperature rise in the tissue. The absorbed energy is converted to heat that results in the 
temperature increase. The SAR can also be expressed in terms of the temperature gradient (T) 







where 𝑐 is the specific heat of the tissue and ∆𝑡 is the treatment time. This definition relates the 




CHAPTER 4: MAGNETIC FLUID HYPERTHERMIA   
 
4.1. Introduction 
Nanoparticles are microscopic particles with dimensions of less than 100 nm. They 
possess a wide variety of potential applications and are now used for medical diagnosis and for 
treatment. Fluorescent semiconductor nanoparticles, known as quantum dots, are used for 
imaging of biological entities [38] and superparamagnetic nanoparticles are used as contrast 
agents for magnetic resonance imaging (MRI) to help diagnose various diseases [39]. 
The multifunctional characteristic of nanoparticles makes them great candidates for 
targeted drug delivery and cancer treatment, and they are currently in use as anti-cancer drug and 
gene carriers for controlling cancer [40]. 
 For cancer therapy, the nanoparticle distribution within the body depends on various 
parameters such as their relatively small size resulting in longer circulation times and their ability 
to take advantage of tumor characteristics. For example, nanoparticles less than 20 nm in size are 
able to pass through blood vessel walls and such small particle size allows for intravenous 
injection as well as intramuscular and subcutaneous applications. The small size of the 
nanoparticles minimizes the irritant reactions at the injection site as compared to conventional 
cancer treatments. Furthermore, nanoparticle size allows for interactions with biomolecules on 
the cell surfaces and within the cells without altering the behavior and biochemical properties of 
those molecules [41]. 
Nanoparticles can be formulated for specific uptake within the body and for a specific 
response by the body to cancer treatment. Nanoparticles can be formulated from a variety of 
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materials so as to carry substances in a controlled and targeted manner. Synthetic polymers, 
which are bio-degradable, are used to prepare the nanoparticles for drug delivery. In 
transportation, this prevents degradation of the carried load and also protects transported 
substances from contact with healthy tissues, hence reducing side effects and increasing the 
relative amount of the load reaching the diseased tissue. 
4.2. Nanoparticle Targeting 
In treatments using nanoparticles, the goal is to have them reach the desired tumor sites, 
after administration, with minimal loss to their volume and activity in blood circulation and to 
attach to tumor cells without harmful effects to healthy tissue. This may be achieved using two 
strategies: passive and active targeting of drugs. 
Passive drugs targeting consists in the transport of nanoparticles through tumor 
capillaries by convection or passive diffusion [42]. Tumor vessels are highly disorganized and 
dilated with a high number of pores, resulting in enlarged gap junctions between endothelial cells 
and compromised lymphatic drainage. In this case, nanoparticles may be released in the 
extracellular matrix and then diffused through the tumor tissue. 
In active targeting, targeting ligands are attached at the surface of the nanoparticle for 
binding to appropriate receptors expressed at the tumor site. The ligand is chosen to bind to a 
receptor of specific tumor cells and not expressed by normal cells [42].  
4.3. Heat Generation of Nanoparticles 
When nanoparticles are exposed to an electromagnetic field, they transform the energy of 
the electromagnetic field into heat by different mechanisms. This transformation depends on the 
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frequency of the external field and on the characteristics of the particles such as their size and 
other characteristics [43 – 45]. 
4.3.1. Hysteresis 
Hysteresis exhibited by magnetic nanoparticles varies depending on the particle size. This 
is shown in Figure.4. Large particles (on the order of microns or more) exhibit a narrow 
hysteresis loop because it takes little magnetic field energy to make the domain walls move 
compared to the energy required to rotate the magnetic moment of the particle. Small particles 
exhibit a broad hysteresis loop. In smaller sizes (on the order of tens of nanometers or less) 
superparamagnetism is observed. These particles have no hysteresis loop because the magnetic 
moment of the particle as a whole is oscillating in response to the thermal energy at room 
temperature. Therefore, superparamagnetic nanoparticles exhibit heat dissipation when exposed 
to an electromagnetic field due to the magnetic relaxation loss [46]. 
 
 






The heat dissipation of superparamagnetic nanoparticles is due to the delay in relaxation 
of the magnetic moment. This relaxation can correspond either to the physical rotation of the 
particles themselves within the fluid, known as Brownian relaxation, or the rotation of the 
magnetic moments within each particle known as Néel relaxation. 
The Brownian 𝜏𝐵 and Néel 𝜏𝑁 relaxation times are given by the following equations: 
 
𝜏𝐵 = 4𝜋𝑟ℎ
3/(𝑘𝑇)  (6) 
 
τN = τ0exp [
KV
kT




where  is the viscosity of the fluid, T the temperature, and 𝑟ℎ is the hydrodynamic radius which 
due to particle coating may be essentially larger than the radius of the magnetic particle core, K 
is the anisotropy constant, 𝑉 is the magnetic volume, and 𝜏0 = 10
−9 𝑠. Since Brownian and Néel 













The relationship between magnetization M and the applied magnetic field H is expressed 
through the magnetic susceptibility , which explains how magnetization varies with  the applied 
magnetic field: 
 
M = H (9) 
 
The Brownian relaxation time is related to the applied magnetic field through the 









 is the equilibrium susceptibility  
The shorter relaxation time term dominates the effective relaxation time for a given 
particle size. 𝜏𝐵 is determined in part by the hydrodynamic properties of the fluid, while  𝜏𝑁 is 
governed by the magnetic anisotropy energy relative to thermal energy. Both Brownian and Néel 
processes may be present in a ferrofluid. In constrained (i.e., immobilized) superparamagnetic 
particles, such as iron oxide, only Néel relaxation occurs.  
Relaxation times are temperature dependent. However for mild hyperthermia at near 
42ºC, the relaxation time constants do not change by much, thus in this investigation the effect of 
small temperature elevations on the time constants are considered negligible. 
The real and imaginary parts of the complex susceptibility can be expressed as shown in 














where 𝜔 = 2𝑓, 𝜏 is the relaxation time. 
0
 is the equilibrium susceptibility, and can be 

































where ∅ is the volume fraction of nanoparticles in the ferrofluid and 𝑀𝑑 is the domain 
magnetization of the nanoparticle, 𝐻0 is the initial magnetic field, 𝑉𝑀 is the volume of 
nanoparticle and 𝑘𝐵 is the Boltzmann constant [45]. 
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Figure 5 shows the real and the imaginary components of the susceptibility as given in 
(11) and (12). These components meet at the peak value of ′′. The imaginary component of 
susceptibility is due to the phase difference between the applied magnetic field and the 
corresponding magnetization and therefore is responsible for generation of heat. ′′ reaches its 
peak value when 𝜔𝜏 = 1.  
 
Figure 5. Real and imaginary components of the susceptibility vs. Frequency 
 
 To understand how the applied magnetic field causes a temperature increase in the 
magnetic nanoparticles, we look at the role played by ′′. 
The magnetic work done on the system is: 
































where 𝐻 (𝐴/𝑚−1) is the magnetic field intensity and 𝐵(𝑇) the induction. The fields are collinear 
and 𝐻 snd 𝐵 are magnitudes. Then, the relation between the magnetic field 𝐻 (𝐴/𝑚) and the 
magnetic flux density (or induction flux) 𝐵 (𝑊𝑏/𝑚2), is: 
 
𝐵 = 𝜇0(𝐻 + 𝑀) (17) 
 
where 𝜇0 is the permeability of free space and 𝑀 is the magnetization of the material (Am
-1) .  
When the magnetization lags the field, the integration yields a positive result indicating 
conversion of magnetic work to internal energy [45], which can be expressed as: 
 
∆𝑈 = −𝜇0 ∮ 𝑀𝑑𝐻 (18) 
where ∆𝑈 is the internal energy. 




′ cos(𝜔𝑡) + ′′ sin(𝜔𝑡)) (19) 
 
where it is seen that ′ is the in-phase component, and ′′ the out-of-phase component of  









The volumetric power dissipation can now be expressed as: 
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where 𝑓is the frequency. 
Hence we see that when magnetic nanoparticles are injected into tumors, their magnetic 
properties are intensified, due to the complex susceptibility ′′.  Consequently, the external H 
field  applied also plays an important role in the heating process. 
From (21), it is observed that the power dissipation is proportional to the square of the 
amplitude of the H field intensity. Therefore, in the bioheat equation (3) written earlier, we 















With nanoparticles injected into a tumor, the heating effect is produced by both the 
electric and magnetic fields generated by the external applicator; i.e., the heating effect produced 
by the external applicator in the tumor, depends not only of the square of E field but also of the 
square of H field.  
When magnetic nanoparticles are present, the relation between the specific absorption 








  (23) 
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where 𝑐 is the specific heat capacity of the sample, 𝑚 is the mass of the magnetic particles, 𝑉𝑠 is 
the total volume of the tissue containing the nanoparticle and 
𝑑𝑇
𝑑𝑡
 is the temperature increment. 
The specific absorption rate SAR is also proportional to the volumetric power dissipation 
P and can be written as: 
𝑆𝐴𝑅 = 𝜌 ∗ 𝑃 = 𝜌𝜋𝜇0
"𝑓|𝐻|2  (24) 
 
where 𝜌  is the density of nanoparticle.  
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 CHAPTER 5: MICROWAVE MAGNETIC FLUID  
HYPERTHERMIA MODELING   
 
 
5.1. Introduction  
The results for enhanced magnetic fluid hyperthermia using magnetic nanoparticles is 
presented for the case of a tumor in the breast tissue. The mathematical modeling is done using 
the Penne’s bioheat equation. Simulations are carried out with HFSS and SEMCAD X [47]. The 
SAR values and the transient temperature are studied as a function of the nanoparticle 
characteristics, such as size, concentration etc. Experiments on phantoms breast and tumor tissue 
were conducted to validate the simulated results obtained.  
5.2. Magnetic Fluid Hyperthermia Design Considerations 
The model consists of a sphere of radius 10 cm representing a single homogeneous breast 
fat tissue. A tumor of 1 cm radius is embedded at the center of the sphere, at 5 cm from the 
surface. The magnetic nanoparticles, immersed in a ferrofluid and are specially coated to target 
and attach to the tumor tissue. The hyperthermia system is shown in Figure 6, where the model is 






Figure 6. Hyperthermia system configuration 
Tumor 





The electric properties of human breast tissue and tumor tissue such as dielectric constant 
and conductivity properties used in the model were assigned according to [12] and the SEMCAD 
X software database [47] and [48]. Table 3 lists these values. 
Table 3. Electrical properties of human tissues 
 
Tissues 𝑟 𝜎 
(S/m) 
Breast Fat 5.28 0.105 
Tumor 60.26 1.21 
 
5.3. Heat Generation 






where 𝑛 is the concentration of the nanoparticles in tissue, 𝑟 is the radius of the 
nanoparticle, " is the magnetic susceptibility and 𝑓 is the frequency. 
To determine the transient temperature, as discussed in Chapter 4, the Penne’s bioheat 
equation in healthy tissue will be: 











and the Penne’s bioheat equation with nanoparticles in the tumor tissue will be: 















The computed heat generation produced by the nanoparticles is included as the heat source 
in the bioheat equation to compute the temperature distribution in the model. 
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Table 4 shows the thermal properties considered for healthy and tumor tissues for use in 
the bioheat equation, according to [47]. 












Breast Fat 916 2524 0.25 0.328 916 
Tumor 1043 3621 0.5 6.807 35 
 
 
5.4. Simulation  
SEMCAD X, a commercial finite-difference time-domain (FDTD) based program for 
analysis of bio-electromagnetic effects along with the software HFSS was used to obtain the 
SAR values and the transient temperatures. The propagating electromagnetic waves are 
generated by an antenna placed near the body with maximum radiation pointing towards the 
body.  In SEMCAD X, the electric field and magnetic field strengths in the human tissue are 
obtained with a sensor called the overall field sensor. SEMCAD X provides thermo-simulation 
where the complete thermal profile of human tissues is obtained taking the blood flow, i.e. the 
density of blood, blood perfusion rate and the blood specific heat, into account.  The program 
allows the determination of SAR values and temperature distribution by using thermosensors. 
Several thermosensors can be placed along the model to record the temperature. For the 
enhanced hyperthermia study in this model the blood flow was not taken into account. 
The specific absorption rate and the temperature profile in the model were first evaluated 
without injecting any nanoparticles into the tumor. The electromagnetic source was set to 50 V 
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and a tumor of 1 cm was located inside the breast phantom at a depth of 50 mm. the total 
treatment time is 1800 sec. The model used in SEMCAD X is shown in Figure 7. 
 
Figure 7. Breast tissue model in SEMCAD X 
 
5.5. Temperature Measurements using SEMCAD X 
Three temperature sensors were used to record temperature increase as the breast tissue 
was illuminated by the electromagnetic wave. These temperature measurements were recorded 
inside the healthy breast phantom and in the ferrofluid with nanoparticles. One sensor was placed 
at the center of the tumor, the remaining two sensors were placed at 2.5 and 5 cm from the first 
sensor, respectively.  
Figure 8 shows the temperature distribution in the breast model obtained from SEMCAD 
X. With no nanoparticles present, there is an insignificant temperature increase in the tumor to 
cause any damage to the cells. Here, the temperature peaks occur right at the boundary of the 
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tissue, where the potential has the largest gradient, and therefore the electric field strength 
appears the maximum in this area. 
 
Figure 8. Tempertaure distribution during hyperthermia without nanoparticles 
 
Magnetic iron oxide nanoparticles, with the properties listed below [49-50] were injected 
into the tumor and the transient temperature was once again studied: 
 
𝑑𝑒𝑛𝑠𝑖𝑡𝑦 (𝜌) = 5180 𝑘𝑔/𝑚3 
𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 (𝑛) = 1𝑥1021 𝑚−3 
𝑡ℎ𝑒𝑟𝑚𝑎𝑙 𝑐𝑜𝑛𝑑𝑢𝑐𝑡𝑖𝑣𝑖𝑡𝑦 (𝐾) = 40 𝑊/𝑚 ∙ ℃ 



























𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 ℎ𝑒𝑎𝑡 (𝐶) = 4000 𝐽/𝑘𝑔 ∙ ℃ 
𝑆𝑎𝑡𝑢𝑟𝑎𝑡𝑖𝑜𝑛 𝑀𝑎𝑔𝑛𝑒𝑡𝑖𝑧𝑎𝑡𝑖𝑜𝑛 (𝑀) = 52 𝑒𝑚𝑢/𝑔 
𝑟𝑎𝑑𝑖𝑢𝑠 (𝑟) = 18 𝑛𝑚 
𝑚𝑎𝑔𝑛𝑒𝑡𝑖𝑐 𝑠𝑢𝑠𝑐𝑒𝑝𝑡𝑖𝑏𝑖𝑙𝑖𝑡𝑦 (") = 65 
 
These results are shown in Figure 9. The temperature at the tumor tissue region is now at 
43.3C, which is the required temperature for hyperthermia treatment. 
 
Figure 9. Tempertaure distribution during hyperthermia with nanoparticles 
 



























The temperature is highest at the breast tissue close to the electromagnetic applicator and 
drops as the distance from the applicator increases. At the tumor location, there is once again an 
increase in the temperature due to the heat generated by the nanoparticles, in the healthy tissue 
the blood flow is not restricted in the capillaries and this allows helps in maintaining the healthy 
temperature. On the other hand, in cancerous tumors the blood flow is restricted significantly 
also contributing to a rise in temperature. This is show in Figure 10. 
 
Figure 10. Time temperature increase in the tissue as function of distance from the applicator 
 
 
5.6. Effect of Nanoparticle Characteristics in the Transient Temperature in the 
Tumor 
For an exposure time of 1800 seconds, various characteristics of the nanoparticles such as 
their size, magnetic susceptibility and concentration were studied to see their effect on the 
transient temperature, once they were introduced into the tumor. 
























5.6.1. Nanoparticle Size 
To test the effect of the nanoparticle size on the tumor heating nanoparticles sizes of 5 
nm, 9 nm and 18 nm were considered. The results from the transient temperature using 
SEMCAD X are shown in Figure 11. It is found that a higher tumor temperature can be induced 
with the particle radius of 18 nm. Larger nanoparticles sizes were not considered in this study 
since, because when the particle size becomes much larger, they lose their superparamagnetism 
characteristic and thus lowering the heat generation capability [51].  
 
Figure 11. Transient temperature in the tumor for different nanoparticles sizes 
 



























Particles with 18 nm diameter showed the highest heating ability obtaining a temperature 
rise T = 6 °C and reaching the target temperature of 43.3 °C. The other nanoparticles 
considered produced only a temperature raise in the range T= 1 – 3 °C. 
To explain this, we evaluated the relaxation times Brownian 𝜏𝐵 and Néel 𝜏𝑁 in section 
4.3.2 equation (8). Here, the Brownian relaxation time 𝜏𝐵 is neglected because it is much larger 
than the Néel 𝜏𝑁 relaxation time in living tissue that has large viscosity. We know that the 
maximum loss is obtained when 𝜔𝜏 ≅ 1 at a critical volume size. At frequency 𝜔 2𝜋⁄ =
2.45 𝐺𝐻𝑧, the optimum relaxation time is 𝜏 = 4 × 10−10 s, which is realized, as shown in Figure 
12, when r is around 18 nm. This coincides with our results. The nanoparticles with 9 and 5 nm 
radius, which have Néel relaxation time far from the optimum relaxation time, exhibit much 
weaker magnetic induction heating as compared to the 18 nm sized particles which has nearly 
optimum relaxation time.  
 
Figure 12. Néel relaxation time 𝜏𝑁 as a function of radius of the nanoparticle 
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5.6.2. Nanoparticle Susceptibility  
Next, we consider the effect of the nanoparticle susceptibility on the heating behavior. 
Susceptibility values of 15, 35, 55 and 65 were considered and the results are shown in Figure 
13. When the nanoparticle susceptibility is 65, the peak of the temperature in the tumor region is 
43.3 C, indicating that a higher susceptibility value provides the desired results for heating the 
tumor.  
 
Figure 13. Transient temperature in the tumor for different nanoparticles susceptibilities  
 
5.6.3. Effect of Nanoparticle Concentration on the Heating Behavior 
Figure 14 shows the influence of the nanoparticle concentration on the increase in the 
tumor temperature. With a magnetic nanoparticles with a concentration equals of 60 𝑚𝑔/𝑚𝑙, we 




























see that the peak temperature in the tumor region is 68 C. Such high temperatures can cause 
thermal injury to the surrounding tissue and are much higher than is needed for hyperthermia. A 
nanoparticle concentration of 40 𝑚𝑔/𝑚𝑙 provides the required temperature level for 
hyperthermia treatment for the exposure time considered. 
 
Figure 14. Transient temperature in the tumor with different nanoparticles concentrations 
 
 
5.6.4. Optimization of Nanoparticle Concentration  
Appropriately choosing the heating dose before performing the hyperthermia is essential 
for proper treatment planning. The relative importance of the heat source induced by the 




























nanoparticles and that in normal tissue can be evaluated through an analysis of equation (22) in 












2                  (23) 
 







                                                 (24) 
 
Which indicates that for a spherical composite the demagnetizing factor of the composite 
tissue 𝑁() = 1/3. 
In hyperthermia, the heat generated by the nanoparticle should always be larger in the 
tumor than that in healthy tissue. The specific power loss of the nanoparticles should be as high 
as possible in order to minimize the heating dose required for the treatment. A criterion to 
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5.7. Experimental Results 
5.7.1. Solid Phantom 
In most instances, experiments cannot be done on human bodies and hence for medical 
research, phantoms are used. A phantom is prepared so as to simulate actual biological tissues 
and allows one to study interactions between applied electromagnetic fields and the human body. 
Phantoms provide a stable, controllable environment for such studies. Phantoms can be prepared 
to simulate the whole body or specific tissues or organs in the body. The ways to prepare these 
phantoms are available in the literature.  
A human breast phantom using corn oil (150 ml), tri-distilled water (50 ml), neutral detergent 
(30 ml), and agarose (4.5 g) [52] was made to simulate the relative permittivity and electrical 
conductivity [12] of human breast fat tissue at 2.45 GHz. Figure 15 shows the phantom breast 
tissue fabricated. The relative permittivity of breast fat is 5.28 and electrical conductivity is 
0.105 S/m for 2.45 GHz. The dielectric constant of the breast phantom was measured using a 
ring resonator [53] and was found to be 5.1 and 0.13 S/m, agreeing well with the reported 
dielectric constants. 
The tumor phantom was made using tri-distilled water (100 ml), ethanol (60 ml), and NaCl 
(1g) mixed together and heated at ∼80◦C for 5 minutes. The measured permittivity for the 




Figure 15. Solid phantom simulating the human breast tissue 
 
Nanoparticles of 39 mg/mL were injected into small spheres of agarose (∼10mm 
diameter), made with 0.006 g/mL of agarose to simulate the tumor tissue, as shown in Figure 16. 




Figure 16. Ferrofluid conatining the nanoparticles and tumor phantom 
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5.7.2. Measurement Setup 
The breast phantom was illuminated at 2.45 GHz with a standard horn antenna, placed at 
6 cm from the phantom, for 30 minutes, as shown in Figure 17. Thermometers were used to 









Figure 17. Measurement setup 
 
 
5.7.3. Temperature Measurements 
The phantom was placed just above the central point of the aperture of the horn antenna 
and the temperature was measured using thermometers placed in the tumor and at two locations 
in the breast phantom 2.5 cm and 5 cm from the tumor. The input power used in each exposure 
to the electromagnetic field was 1 W and each exposure was for 1800 s. The initial temperature 
of both the healthy and the tumor phantom was the room temperature of 21 C, and the 
temperature increment ∆𝑇 was measured with the thermometer.  
Thermometer 




First, temperatures were taken in the phantom without nanoparticles injected. The results 
are shown in Figure 18. It can be seen that there is no significant change in temperature ∆𝑇.  
 
Figure 18. Temperature in phantom without nanoparticles 
 
Then, the temperature was measured at the same locations after injecting nanoparticles 
into the tumor. The results obtained are presented in Figure 19. 
















Thermosensor 1 (5 cm)
Interpolation






Figure 19. Temperature in phantom with nanoparticles 
 
The measurements validate the results obtained with the simulations. There is an increase 
in the tumor around 6 - 7C, which indicates that the nanoparticles exhibit a highly focused 
heating in the tumor tissue region, which is much higher than that in the surrounding healthy 
tissue.    
















Thermosensor 1 (5 cm)
Interpolation





CHAPTER 6: MAGNETIC FLUID HYPERTHERMIA INCORPORATING 
BLOOD FLOW  
 
 
6.1. Introduction  
The response of human tissues to hyperthermia treatment is influenced by a number of 
physical, physiological, biochemical, and immunological factors which determine its 
effectiveness. A knowledge of these influences is essential to improve the results presently 
obtained by tumor treatment with hyperthermia alone or in combination with radiotherapy or 
chemotherapy.  
The major physiological factor that has been of great interest to a number of investigators 
is the blood flow [54-57]. It is known that temperature distributions within the tumor and 
surrounding normal tissue during hyperthermia are influenced primarily by convective heat 
transfer between the blood and tissue bed. The local blood perfusion rate plays a major role 
during hyperthermia [57]. The blood flow causes a cooling effect in the tissues. 
When hyperthermia is used in combination other cancer treatments, such as radiotherapy 
and chemotherapy, the sequence of therapy is governed by the role blood flow plays in each of 
these modalities.  
6.2. Blood Perfusion in Humans 
Studies on blood perfusion in tissues have proven that the blood perfusion in tumors 
varies significantly with type, phase and size of the tumor. Also, the greater the blood perfusion 
rate of the tissue is, the greater the cooling effect. An important point is that the significant 
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differences between the blood perfusion rate of normal tissue and that of tumors causes selective 
heating of tumors in hyperthermia [56]. Table 5 shows the typical blood perfusion rate for 
various tissues and organs [58]. 
 
Table 5. Blood perfusion in human tissues 
 
Tissue Type Anatomical Location or Organ Specific Blood Flow Rate 
(mm3/sec-gm) 




Bone Humerus, marrow flow only 0.055 
Connective tissue Typical, basal 0.50 
Joint Knee 0.487 
Muscle Calf, anterior, (max) 
Forearm, (max) 
Thigh, anterior, (max) 





Organ Brain, basal (max) 
Gastrointestinal tract, basal (max) 
Heart, basal (max) 
Kidney, basal (max) 
Liver, basal (max) 































In liver tissue, which we will study here, the lower blood perfusion in tumorous tissues 
results in some protection for the surrounding healthy tissue during local hyperthermia treatment. 
The normal liver receives two-thirds of its blood supply from the portal vein system, whereas 
tumors in the liver derive virtually all of their blood supply from the hepatic arterial system. 
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Thus, for hepatic tumors, substances injected into the hepatic arterial system will be 
preferentially delivered to the liver tumor [59]. Hence, the use of magnetic nanoparticles by 
injecting them into the tumor via arterial embolization, provides an effective way to kill tumor 
cells. 
In arterial embolization, also known as trans-arterial embolization (or TAE), a catheter (a 
thin, flexible tube) is inserted into an artery through a small cut in the inner thigh and threaded 
up into the hepatic artery in the liver. A dye is injected into the bloodstream so that the doctor 
monitor the path of the catheter via angiography. The nanoparticles can then be injected through 
the catheter. 
 
6.3. Magnetic Fluid Hyperthermia Design Incorporating the Blood Perfusion  
The use of enhanced hyperthermia with magnetic nanoparticles (also referred to as 
magnetic fluid hyperthermia) was studied for liver tumor by incorporating blood perfusion.  Case 
simulations were performed using a male human model [47], shown in Figure 20, provided by 
SEMCAD X. SEMCAD X provides the complete 2.5D rendering of a typical adult male human 
body including bones, skin, heart, brain (grey matter), brain (white matter) etc. Each tissue and 
organ can be assigned relative permittivity and conductivity values that can be used to determine 
an objects complex permittivity and loss tangent. For accurate modelling at a given frequency, f, 
the Gabriel tissue parameters [12] can be calculated and imported into SEMCAD X. Typically 
for any body part the conductivity increases as the frequency increases and the relative 




Figure 20. Human model in SEMCAD X 
 
In this research, liver tumor models with the different blood perfusion rates labeled as 
models 1–5, as shown in Table 6, were studied. The blood perfusion rates were assumed to be 
homogeneous in the tumor and to be 100% (model 1), 75% (model 2), 50% (model 3), 25% 
(model 4) and 5% (model 5) of that of the liver. Model 5 has the typical blood perfusion rates for 
the tumor and normal tissues reported in literature [58]. Also, the blood perfusion rates of these 
models were assumed to be unchanged with changes in temperature. This assumption is made to 
simplify the comparison between the effects of the ratio between the normal and tumor tissue 
blood perfusion rates.  
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Table 6. Models with different blood perfusion rates 
 
Model Tumor Blood Perfusion 
(ml/min/kg) 
Liver Blood Perfusion 
(ml/min/kg) 
1 600 600 
2 450 600 
3 300 600 
4 150 600 
5 30 600 
 
For this study, the liver and tumor are illuminated at 2.45 GHz with a standard horn 
antenna placed close to the surface of the body.  A 1 cm tumor size is located inside the left lobe 
of the liver at approximately 50 mm from the surface. A ferrofluid containing iron oxide 
nanoparticles of concentration 40 mg/mL was injected into the tumor. 
6.4. Simulated Transient Temperature  
In SEMCAD, X six temperature sensors were used to record the increase in temperature. 
One sensor was placed at the center of the tumor, the remaining sensors were placed in the 
healthy liver tissue at 0.5, 2, 3, 4 and 5 cm from the tumor.   
The temperatures obtained from the simulation by the sensors for the models 1-5 
considered, are shown in Figures 21-25. 
Figure 21 shows the transient temperature in model 1 where the blood flow in the tumor 
tissue is equal to that in the healthy liver, the temperature reaches a value of 37.5 C after 1800 
sec of exposure to the electromagnetic radiation. Since the blood perfusion in the tumor was 
equal to that of the healthy liver, selective heating of the tumor was difficult.  
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Figure 21. Transient temperature in the l.iver model – Blood perfusion rate 100% 
 
 
Figure 22. Transient temperature in the l.iver model – Blood perfusion rate 75% 
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Thermosensor 5 (5 cm)
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Tumor blood flow = 100% liver blood flow 
Tumor blood flow = 75% liver blood flow 
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Figure 23. Transient temperature in the liver model – Blood perfusion rate 50% 
 
 
Figure 24. Transient temperature in the l.iver model – Blood perfusion rate 25% 
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Figure 25. Transient temperature in the l.iver model – Blood perfusion rate 5% 
 
In models 1– 4, with blood perfusion rates 100% to 25%, the lower blood perfusion in the 
tumors makes selective heating of the tumors easier. The healthy tissue does not shown an 
increased temperature. This is seen in Figures 21-24. 
A comparison of the resultant tissue temperatures using models 1–5 indicates that 
temperatures in the tumor reached 43 C in model 5, with blood perfusion rate of 5%, as seen in 
Figure 25. 
This reinforces the importance of taking the blood perfusion into account in hyperthermia 
treatment. The normal blood flow in the healthy tissues keeps their temperature from raising to 
high, dangerous levels. 
Figure 26 is a comparative plot of the healthy tissue and the tumor for the models studied. 
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Figure 26. Temperature comparison in the tumor and healthy tissue  
 
The SAR values, obtained from SEMCAD X, with blood perfusion included are shown in 
Figure 27. Once again, we see that in model 5 we get the high SAR values in the tumor, suitable 
for hyperthermia, while the healthy tissue SAR values stay at a safe level. 
 
Figure 27. SAR comparison in the tumor and healthy tissue  





















































Since the nanoparticle characteristics play a major role in the heating and the SAR for 
hyperthermia, a study of the effect of the nanoparticle concentration was done while including 
the blood perfusion. The particle radius was kept at 18 mm and the concentration were varied 
from 40 mg/mL to 60 mg/mL for each of the five models.  
The results for the temperature in the tumor are shown in Figure 28. For model 5, with 
the lowest blood perfusion, a concentration of 40 mg/mL gives the desired temperature for 
hyperthermia. 
 
Figure 28. Temperature increase in the tumor as a function of nanoparticle concentration  
 































6.5. Experimental Results using a Simplified Phantom 
A simplified phantom model was made to carry out an experimental demonstration of the 
blood flow cooling effect in magnetic fluid hyperthermia. Figure 29 shows a cylindrical solid 
phantom liver size L= 6 cm and r = 8.5 cm. In this research, only the hepatic portal vein is 
considered. The hepatic portal vein is modelled as a cylindrical hole of 20 mm in diameter within 
the phantom. Saline solution poured through the liver phantom was used to simulate the cooling 
effect due to blood flow in the vein. The velocity of the saline solution is controlled by changing 
the diameter of a small hole in a rubber sheet placed at the bottom of the phantom.  
The relative permittivity of this phantom is 47 and the conductivity is 2.2 S/m, which is 
equivalent to the electrical constants of human liver at 2.45 GHz. A 0.35 % saline solution is 
poured into the cylindrical hole modeling the hepatic portal vein. The value of the conductivity 
of the 0.35 % saline solution is 2.1 S/m, which is almost the same value that the human blood at 
2.45 GHz. During the experiment, the saline solution is poured continuously. The permittivity of 
the tumor phantom was 59 and it was injected with iron oxide nanoparticle concentration of 40 






Figure 29. Simplified liver model 
Saline Solution 
Tumor 
𝑟 = 8.5 cm 









The resistance blood flow depends on several factors including radius, length, and 
viscosity of the blood. The resistance can be expressed as: 
                                                           𝑅 =
𝑉𝐷

                                             (31) 
where  is the blood density, V is the blood velocity, D is the diameter of the vein and  is the 
blood viscosity [ = 1.0 × 10−6 𝐽/𝑘𝑔 ∙ 𝐾].  
 In the experiment, the velocity of blood flow is varied by changing the diameter of the 
hole on a rubber sheet placed at the bottom of the phantom. For each one of the five models 
considered, a specific diameter of the hole was determined to obtain the corresponding blood 
flow velocity. 
The total exposure time to the electromagnetic radiation was 1800 seconds, and the input 
power to the antenna was 1W. The initial temperature of the phantom and saline solution was 




















Figure 30. Liver phantom measurement setup – Side view 
 
and Figure 31 is a top view of the liver phantom model showing the cylindrical holes to pour 
saline solution into. 
 









6.6. Measured Temperatures 
The phantom was placed in front of the 2.45 GHz horn antenna. The temperature was 
measured using the thermometer at five locations in the phantom and at one location in the tumor 
for a period of 1800 sec.  
As mentioned earlier, the flow of the saline solution was controlled by changing the size 
of the hole on the rubber sheet at the bottom of the phantom, to model the five blood perfusion 
rates studied. The results are shown in Figures 32-36. The temperature increment T C above 
the normal temperature of 37 C is shown. There is a noticeable increase in temperature for 
models 3 and 4, but once again, we see that in model 5, we obtain a T between 5 and 6 C 
which is what is desirable for hyperthermia. This agrees with the results obtained in the 
simulations. 
  
Figure 32. Temperature measured in healthy and tumor tissues in the model 1 
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Tumor blood flow = 100% liver blood flow 
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Figure 33. Temperature measured in healthy and tumor tissues in the model 2 
 
  
Figure 34. Temperature measured in healthy and tumor tissues in the model 3 
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Figure 35. Temperature measured in healthy and tumor tissues in the model 4 
  
Figure 36. Temperature measured in healthy and tumor tissues in the model 5 
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6.7. Use of Magnetic Fluid Hyperthermia in Human Tissues 
Although magnetic fluid hyperthermia is an effective cancer therapy, there are limitations 
that restrict its use to tumors growing in specific tissues in the body. These limitations include 
blood perfusion, which leads to large amount of blood removing heat from the tissue and the size 
the nanoparticles, which may restrict them from traveling into the smaller capillaries inside the 
tumor. Such restrictions prevent magnetic fluid hyperthermia from treating brain tumors where 
the blood-brain barrier does not allow effective injection of nanoparticles into the tumor. In lung 
tissues, the high blood perfusion results in rapid heat dissipation even before the nanoparticles 
can even reach the desired increased temperature needed to kill the cancerous cells. The low heat 
diffusivity and difficulty in pinpointing tumor locations in bone cancer also makes magnetic 
fluid hyperthermia a less effective treatment approach.  
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CHAPTER 7: CONCLUSIONS 
 
 
The technical challenge in hyperthermia treatment is to heat the tumor to the appropriate 
therapeutic temperature without causing damage to the surrounding healthy tissue. The results 
presented in this research show that conventional hyperthermia treatment can be enhanced 
through the use of magnetic nanoparticles.  
A system with a microwave applicator at 2.45 GHz, magnetic nanoparticles and 
temperature monitoring sensors was modeled to effectively study hyperthermia treatment for 
cancerous tissues in the breast and in the liver.  
Simulated results for enhanced hyperthermia breast cancer were obtained using HFSS 
and SEMCAD X and values for the SAR and transient temperature in the healthy tissue and the 
tumor were presented. Using Penne’s bioheat transfer equation and comparing results with and 
without iron oxide nanoparticles injected in the tumor, it was seen that the presence of 
nanoparticles allowed for the required increase in temperature in a short period of time. Various 
characteristics of the nanoparticles such as size, concentration, and susceptibility were 
considered. It was seen that a radius of 18 nm and a concentration of 40 mg/mL provided the 
most desirable results. Temperatures in the tumor reached that required to kill the cancer cells 
while the healthy tissue remained at a safe temperatures. 
Experiments were conducted on a phantom model and the results validated those 
obtained through simulations. 
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As the blood flow in the body plays an important role in maintaining the body 
temperature, the effect of blood perfusion in magnetic fluid hyperthermia was also studied. Here, 
a tumor in the liver was injected with nanoparticles and five different blood perfusion rates were 
studied. Using a human male model, available in SEMCAD X, and appropriate values for the 
dielectric constant and conductivities in the tissue, the incremental increase in the temperature 
was obtained in the liver and in the tumor. When the blood perfusion rate in the tumor was low, 
as in the case found in liver tumors, the rise in temperature was higher in the tumor than in the 
healthy tissue.  
Experiments were done using a liver phantom model and allowing 0.35% saline solution 
flow through it to simulate blood flow. The results obtained agree with those of the SEMCAD X 
simulation.  
It was shown that the use of magnetic nanoparticles does provide a more effective 
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